文献速递肝病

1996至2016年美国慢性肝病与肝硬化经济负担趋势

Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

INTRODUCTION: The management of chronic liver diseases (CLDs) and cirrhosis is associated with substantial healthcare costs. We aimed to estimate trends in national healthcare spending for patients with CLDs or cirrhosis between 1996 and 2016 in the United States.…

要点

  • 1996至2016年总体支出年均增长4.3%(95%CI 2.8%-5.8%)。
  • 人均支出2008年后开始下降,年均变化-1.7%(95%CI -2.1%至-1.2%)。

核心结论

  • 美国慢性肝病与肝硬化医疗支出巨大,且不成比例地由急性住院服务驱动。

研究设计与样本

  • 基于健康计量与评估研究所疾病支出项目的国家医疗支出数据和全球疾病负担研究的患病率,估计1996至2016年通胀调整后的美国医疗支出趋势,按护理场所分层,使用Joinpoint回归分析年度百分比变化(APC)及95%置信区间。

主要发现

  • 1996至2016年总体医疗支出每年增长4.3%(95%CI 2.8%-5.8%),由医院服务价格和强度每年增长17.8%(95%CI 14.5%-21.6%)驱动。
  • 慢性肝病或肝硬化患者人均总医疗支出在2008年后开始下降(APC -1.7% [95%CI -2.1%至-1.2%]),主要因门诊护理支出减少(2011年后APC -9.1% [95%CI -10.7%至-7.5%])。

临床怎么用

  • 临床应关注慢性肝病与肝硬化患者住院和急诊服务的高支出,优化急性期管理可能有助于控制经济负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The management of chronic liver diseases (CLDs) and cirrhosis is associated with substantial healthcare costs. We aimed to estimate trends in national healthcare spending for patients with CLDs or cirrhosis between 1996 and 2016 in the United States. METHODS: National-level healthcare expenditure data developed by the Institute for Health Metrics and Evaluations for the Disease Expenditure Project and prevalence of CLDs and cirrhosis derived from the Global Burden of Diseases Study were used to estimate temporal trends in inflation-adjusted US healthcare spending, stratified by setting of care (ambulatory, inpatient, emergency department, and nursing care). Joinpoint regression was used to evaluate temporal trends, expressed as annual percent change (APC) with 95% confidence intervals (CIs). Drivers of change in spending for ambulatory and inpatient services were also evaluated. RESULTS: Total expenditures in 2016 were $32.5 billion (95% CI, $27.0-$40.4 billion). Over 65% of spending was for inpatient or emergency department care. From 1996 to 2016, there was a 4.3%/year (95% CI, 2.8%-5.8%) increase in overall healthcare spending for patients with CLDs or cirrhosis, driven by a 17.8%/year (95% CI, 14.5%-21.6%) increase in price and intensity of hospital-based services. Total healthcare spending per patient with CLDs or cirrhosis began decreasing after 2008 (APC -1.7% [95% CI, -2.1% to -1.2%]), primarily because of reductions in ambulatory care spending (APC -9.1% [95% CI, -10.7% to -7.5%] after 2011). DISCUSSION: Healthcare expenditures for CLDs or cirrhosis are substantial in the United States, driven disproportionately by acute care in-hospital spending.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ma C, Qian AS, Nguyen NH, et al. Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016. Am J Gastroenterol. 2021. PMID: 33998785. doi:10.14309/ajg.0000000000001292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。